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Abstract
Background:  The presence of functional 5-HT4 receptors in human and its involvement in
neonatal lupus erythematosus (NLE) have prompted us to study the receptor expression and role
during embryogenesis. Earlier we managed to demonstrate that female BALB/c mice immunized
against the second extracellular loop (SEL) of the 5-HT4 receptor gave birth to pups with heart
block. To explain this phenomenon we investigated the expression of 5-HT4 receptors during
mouse embryogenesis. At the same time we looked whether the consequence of 5-HT4 receptor
immunomodulation observed earlier is in relation to receptor expression.
We studied the expression of 5-HT4 receptor at the mRNA level and its two isoforms 5-HT4(a) and
5-HT4(d) at the protein level in embryos from BALB/c mice, at 8th, 12th, 18th gestation days (GD)
and 1 day post natal (DPN). Simultaneously the receptor activity was inhibited by rising antibodies,
in female mice against SEL of the receptor. The mice were mated and embryos were collected at
8th, 12th, 18th GD and 1 DPN.
Results:  5-HT4 receptor mRNA increased in brain from 12th GD to 1 DPN. Its expression
gradually decreased in heart and disappeared at birth. This was consistent with expression of the
receptor isoforms 5-HT4(a) and (d). Abnormalities like decreased number of embryos, growth delay,
spina bifida and sinus arrhythmia from 12th GD were documented in pups of mice showing anti-5-
HT4 receptor antibodies.
Conclusion: serotoninergic 5-HT4 receptor plays an important role in mouse foetal development.
In BALB/c mice there is a direct relation between the expression of receptor and the deleterious
effect of maternal anti-5-HT4 receptor autoantibodies in early embryogenesis.
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Background
Serotoninergic 5-HT4 receptors belong to the family of 7-
membrane spanning receptors coupled to Gs  protein.
Until now 10 different human isoforms have been cloned
and sequenced (h5-HT4(a), (b), (c), (d), (e), (f), (g), (hb), (i) and (n))
[1-3] They are all coded by a complex gene (700 Kb, 38
exons), which generates 9 carboxy-terminal variants
issued from alternative splicing. They have identical
sequences up to Leu358, with the exception of h5-HT4(hb),
which is characterized by a 14 amino acid residues inser-
tion within the receptor second extracellular loop (SEL) of
h5-HT4(b) [4]. The presence of 5-HT4 receptor has been
reported in different tissues. Receptor mRNA has been
detected in brain, bladder, gastrointestinal tract, heart,
kidney, pancreas and testis [3,5,6]. In postmortem human
brain studies the receptor, ignoring its different isoforms,
was detected in the basal ganglion (caudate nucleus, puta-
men, nucleus accumbens, globus pallidus and substantia
nigra), in cortex and hippocampus (CA1 and subiculum)
[7]. In heart, mRNA for different h5-HT4  isoforms is
mainly detected in atrium (5-HT4(a), (b), (c), (g), (i)) [3,5]. The
presence of four isoforms, mainly m5-HT4(a), (b), (e), (f) has
been described in mouse [8,9]. Although many studies
have been performed to highlight the tissue distribution
and functional activity of different isoforms of the recep-
tor in adult human, rat and mouse, little is known about
their expression and function during embryogenesis. Pre-
viously we have reported the involvement of 5-HT4 recep-
tor in congenital heart block (CHB) associated to a
systemic autoimmune response in the mother [10]. In
neonatal lupus erythematosus (NLE), autoantibodies
against ribonucleoproteins 48-kDa SSB/La, 52-kDa SSA/
Ro (Ro52) and 60-kDa SSA/Ro (Ro60) have received
more attention, since they have been shown to be strongly
associated with autoimmune responses involved in symp-
toms like CHB [11]. It has been postulated that the trans-
fer of maternal anti-Ro52 antibodies from mother to the
fetus is responsible for the symptoms of NLE. In a previ-
ous study, we managed to induce NLE symptoms in a
mouse model [12]. This has prompted us to further
explore the expression of different 5-HT4 receptor iso-
forms in BALB/c mice during embryogenesis. Meanwhile,
we searched for the period when anti-receptor antibodies
could induce the observed abnormalities.
Results and Discussion
1. Production of anti-peptide antibodies
Peptides derived from C-terminal ends of 5-HT4 receptor
isoforms (Y23F and carrier- C7F) were highly immuno-
genic. The anti-5-HT4(a) and 5-HT4(d) antibodies were able
to recognize both their homologue peptide in ELISA. The
specificity of the recognition was tested by inhibition
immunoassay (Figure 1). No cross-reactivity between the
different anti-isoforms antibodies was detected in ELISA
(data not shown). The antibodies recognized their corre-
sponding receptor isoforms in immunocytofluorescence
performed on transfected CHO cells (Figure 2). On trans-
fected CHO cells, anti- 5-HT4(a) antibodies were specific
for their corresponding isoform while anti-5-HT4(d) ones
recognized 5-HT4(a), (b), (c) and (d) isoforms.
2. Expression of receptor isoforms
Embryos from 8 pregnant BALB/c mice gestation days
(GD) 8th, 12th, 16th, 18th, 20th and one day postnatal
(DPN) were collected. These were used to explore the
expression of 5-HT4 receptor isoforms both at the mRNA
(RT-PCR) and protein levels. RT-PCR experiments
revealed the increased expression of 5-HT4 receptor iso-
forms from day 12 of gestation to day 1 postnatal in brain.
Receptor mRNA expression in the heart decreased gradu-
ally and disappeared at birth (Figure 3a). The latter was
confirmed at the protein level where the expression of
both isoforms matched the expressed 5-HT4  receptor
mRNA (Figure 3b and 3c). In adult mouse brain we
detected both anti-5-HT4(a) and anti-5-HT4(d). Interest-
ingly, the 5-HT4(a) receptor is absent in dentate gyrus of
adult mouse hippocampus (Figure 3d).
3. In vivo effect of anti-5-HT4 antibodies
In order to highlight the role of 5-HT4 receptor on normal
development of the embryos, we sought to immunomod-
ulate the activity of the receptor in BALB/c mice embryos,
through the passage of maternal anti-receptor antibodies
induced with a peptide corresponding to the second extra-
cellular loop of the 5-HT4 receptor. Pregnant mice at 8th,
12th, 18th  GD and one DPN were sacrificed and the
Inhibition enzyme immunoassay showing the specificity of  anti-Y23F () and anti-C7F (■) antibodies for their corre- sponding peptides Figure 1
Inhibition enzyme immunoassay showing the specificity of 
anti-Y23F () and anti-C7F (■) antibodies for their corre-
sponding peptides. Mean values ± SD of the inhibition per-
centage obtained with increasing amount of peptides are 
represented.BMC Developmental Biology 2007, 7:34 http://www.biomedcentral.com/1471-213X/7/34
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embryos were counted and collected for morphological
studies.
All female mice immunized with G21V developed high-
titre anti-peptide antibodies. Serum from the mouse hav-
ing a fetus with spina bifida, recognized the 5-HT4 recep-
tor by flow cytometry analyses performed on CHO cells
transfected with 5-HT4(g) receptor (Figure 4). The same
antibodies did not recognize any expression protein on
CH0 cells transfected with M2  muscarinic receptor.
Although immunized mice were all pregnant between 4 to
8 days post-mating, no pups were delivered at 21st day
post-fertility. Mice had to be mated more than three times
over a period of 2 months for a successful pregnancy. This
was probably due to the presence of anti-5-HT4 receptor
antibodies. The fact that the female BALB/c mice had cir-
culating anti-peptide antibodies did not alter their fertility
but jeopardized the normal development of embryos. The
latter was confirmed by the abnormal number of embryos
collected at different periods of gestation. In addition we
have also observed and documented different symptoms
such as growth delay, spina bifida, arrhythmia and ataxia,
which all started from the 12th gestation day to 1 day PN
(Table 1 and Figure 5a, b). Control mice (n = 5) gave birth
to normal number of pups 21 days after the first mating
(14 pups in total). The number of fetus in different embry-
onic periods was also normal i.e. 7 embryo in average (20
fetus in total). No abnormalities were observed neither in
the embryos nor in the fetuses of the control did female
mice, which were administer only CFA and mBSA.
Table 2 summarises the titer of circulating anti-receptor
antibodies, number of pups and abnormalities observed.
Morphological studies showed either growth delay or late
development of foetal hindbrain at 12th GD (Figures 5A,
5B). Histological studies showed, besides the presence of
spina bifida, delayed foetal neuronal differentiation in
embryos from the mother with circulating anti-5-HT4
antibodies. In the heart of the same embryo symmetric
form of the heart was observed with pronounced hyper-
plasia and decreased fibroblast density (Figure 5B). The
latter was confirmed with decreased immunoreactivity for
α-SMA in the heart of the embryos from the mouse with
circulating anti-5-HT4 antibodies (Figure 6A, 6B)
Conclusion
Up to now there is no information on the distribution of
the 5-HT4 receptor isoforms at the protein level. The fact
that there are at least 10 different 5-HT4 receptor isoforms
and mRNA expression in both central and peripheral
organs, point to the importance of this family of receptors
in the maintenance of normal cellular activity. Although
5-HT4 receptor has been reported to be involved in mem-
ory and learning as well as gastrointestinal function, less
or almost nothing is known about its role in embryogen-
esis.
The importance of the embryonic serotoninergic system
in central nervous and cardiovascular functions has been
largely described [15-20]. In early mouse embryogenesis,
maternal serotonin (5-HT) activates different 5-HT recep-
tors to control gene expression, migration and prolifera-
tion of neuronal crest and neuronal-crest derived cells
[21-25]. Although there is enough evidence fortifying the
5-HT hypothesis in embryogenesis, no major abnormali-
ties were found in 5-HT4 receptor knockout mice. One has
just observed an attenuated response to stress and novelty
as well as hypersensitivity to seizures [31]. There are many
knockout and transgenic mouse models with such pheno-
types. For instance null mutation of α4 subunit nicotinic
Specificity of anti-5-HT4(a) and anti-5-HT4(d) antibodies for  their corresponding isoforms transiently expressed in CHO  cells Figure 2
Specificity of anti-5-HT4(a) and anti-5-HT4(d) antibodies for 
their corresponding isoforms transiently expressed in CHO 
cells. Merge of DAPI nuclear staining and immunolabelling are 
shown. Anti-5-HT4(a) antibodies bind only their correspond-
ing isoform, while anti-5-HT4(d) binds all isoforms (5-HT4(a), 
(b), (c) and (d)). No labelling was obtained with non -transfected 
cells.BMC Developmental Biology 2007, 7:34 http://www.biomedcentral.com/1471-213X/7/34
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cholinergic receptor increases the susceptibility to procon-
vulsant-induced seizures [32]. This is also the case for 5-
HT1A  receptor, prion protein, superoxide dismutase,
tumor necrosis factor-alpha [32-34] and many others.
Blocking the expression
of 5-HT receptors using traditional knockout method
gives rise to compensatory mechanism that occur during
the constitutive deletion of the receptor throughout the
lifespan of the animal. Furthermore, the inherent com-
plexity in the pattern of expression and in the function of
some genes and gene products contributes more to com-
pensation and hidden developmental roles [35]. On the
contrary by using alternative methods like blocking the
expression of the receptor in restricted periods of time one
circumvents the compensations [32]. The latter is also
possible by modulating the protein activity at the cell
membrane rather than blocking the function of the gene.
Given the pathophysiological complexity of these condi-
tions and involvement of many other factors one cannot
explain these abnormal conditions with the lack of 5-HT4
receptors. One plausible explanation to the latter is the
expanded variety of the 5-HT receptor family. Loosing one
receptor subtype or isoform probably leads to a compen-
sation mechanism conducted by other members of the
family here probably 5-HT6 serotoninergic receptor. The
only 5-HT receptor knockout with pathophysiological
consequences is the 5-HT2(b) receptor. 5-HT2(b) receptor
A) Expression analysis of 5-HT4 receptor transcripts in embryonic and post-natal mouse tissues Figure 3
A) Expression analysis of 5-HT4 receptor transcripts in embryonic and post-natal mouse tissues. RT-PCR analysis was per-
formed with RNA extracted from various mouse tissues (the brain (B), the eye (E), the heart (H), and the trunk (T). The 12th, 
16th, 20th GD and 1 DPN are represented in lane 1–2, 3–5, 6–8 and 9–11 respectively. The PCR products were analysed on a 
1.5% agarose gel and photographs of the ethidium bromide stained gels are shown (upper panel). The PCR primers used for 
this analysis and expected length of the PCR products are described in Materials and Methods. A positive control was per-
formed with β-actin primers on mRNA samples treated with reverse transcriptase. This figure is representative of three sepa-
rate determinations of mouse 5-HT4 receptor mRNA expression obtained by RT-PCR. The specificity of the PCR products 
were analysed by Southern blotting using a 32P-5'-end-labeled internal primer (lower panel). A 3 h exposure of the autoradio-
gram is shown. Positions of the molecular weight markers are indicated in bp. m5-HT4R, mouse 5-HT4 receptor; Marker, 
molecular weight marker. 3B-D) Normal receptor expression at protein level detected using anti-5-HT4(a) and anti-5-HT4(d) 
antibodies in heart (B) atrium (a) myocardium (M) ventricle (V) brain, (C) in cortex (c) hippocampus (CA1) frontal cortex (FC), 
during different embryonic periods and at birth. Figure 3D shows the normal expression of 5-HT4 receptor in hippocampus of 
adult BALB/c mouse. Immunolabelling is shown in the left panel and DAPI nuclear coloration in the right one.BMC Developmental Biology 2007, 7:34 http://www.biomedcentral.com/1471-213X/7/34
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knockout mice embryos developed cardiac hypoplasia
[24]. The receptor's importance in regulating cardiac activ-
ity was reported two years later [26]. Our group has shown
in pups of BALB/c mice that maternal anti-5-HT4 antibod-
ies caused fetal cardiac hyperplasia and arrhythmia [12].
In the central nervous system, 5-HT4 receptor isoform
mRNAs were found in almost all brain structures. How-
ever, up to now neither the receptor expression nor its
function during the fetal period was studied.
In the first part of this study, we demonstrated the specif-
icity of the anti-peptide antibodies for their corresponding
peptide. Anti-5HT4(a) was specific for its isoform as it did
not cross react with any of the other receptor isoforms
tested, i.e. 5-HT4(b), (c) and (d). On the contrary, 5-HT4(d)
antibodies, besides binding its corresponding peptide
could also recognize all the other isoforms including 5-
HT4(a). This was not due to a cross reactivity but to their
specificity, since the C- terminal end of 5-HT4(d) is com-
mon between 5-HT4(a), (b), (c) and (d). We report here the
presence of cardiac isoforms 5-HT4(a) in embryos from
BALB/c mice at GD 8th (data not shown), 12th, 18th and
one day postnatal. Since the anti-5-HT4(d) antibodies are
able to recognize other already mentioned isoforms, we
can only be sure about the expression of 5-HT4(a) in the
heart and brain. Whether there are other isoforms
expressed during embryogenesis remains elusive. How-
ever 5-HT4(a) receptor was found both in fetal brain and
heart. Both 5-HT4(a) and 5-HT4(d) receptor isoforms were
expressed in brain, at 1 DP, but we could not detect any
signal in the pups' heart for the two explored isoforms.
One remains, however, puzzled of the receptor's disap-
pearance at 1 DP. This could be explained by the progres-
sive appearance of adrenergic receptors. Indeed, both α-
and β-adrenergic receptors are already detected at 12th GD,
and, contrary to 5-HT4 receptor, activity of β-adrenergic
receptor in mouse heart increases significantly until birth
[27].
In the second part of our study, we observed that all
female BALB/c mice immunized with peptide derived
from the second extracellular loop of 5-HT4  receptor
developed anti-peptide antibodies that could recognize
membranes from 5-HT4(g)  transfected CHO cells.
Although the mice were all fertile, they had to be mated
several times before developing a successful pregnancy.
All mice in the control group gave birth 21 days post mat-
ing. In immunized mice, the number of pups for the first
Table 1: The outcome of mated mice immunised with G21V peptide
Mouse Titre Fetus number Observed alteration Period
1 1/200 7 1 growth delay 12 GD
2 1/1600 7 1 spina bifida 12 GD
3 1/1600 2 1 arrhythmia and 1 growth delay 18 GD
4 1/800 2 1 ataxia 1 DPN
5 1/100 6 1 arrhythmia and 1 growth delay 1 DPN
Summary of the outcome at different development intervals from female BALB/c mice immunized with G21V peptide. There is a relation between 
anti-G21V antibodies titre and number of fetuses/pups.
Showing the recognition of 5-HT4(g) receptor expressed in  CHO cells (upper figure)using sera from immunized mouse  with anti-5-HT4 antibodies (red), and positive controls, i.e.  affinity-purified polyclonal rabbit anti-5-HT4 antibodies (blue)  as well as affinity purified human anti-5-HT4 antibodies from a  patient with lupus (green) Figure 4
Showing the recognition of 5-HT4(g) receptor expressed in 
CHO cells (upper figure)using sera from immunized mouse 
with anti-5-HT4 antibodies (red), and positive controls, i.e. 
affinity-purified polyclonal rabbit anti-5-HT4 antibodies (blue) 
as well as affinity purified human anti-5-HT4 antibodies from a 
patient with lupus (green). The same antibodies showed no 
recognition of M2 muscarinic receptor expressed in CHO 
cells (lower figure).BMC Developmental Biology 2007, 7:34 http://www.biomedcentral.com/1471-213X/7/34
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Morphological (A) and histological (B, C and D) studies on fetus from BALB/c mice immunized either with G21V (right) or with  CFA (left) Figure 5
Morphological (A) and histological (B, C and D) studies on fetus from BALB/c mice immunized either with G21V (right) or with 
CFA (left). Note the difference in size (A2), delayed neuronal folding (A2 & 4), absence of hindbrain (arrow) and open neuronal 
tube (*) in fetus from mouse with anti-5-HT4 antibodies. Figures 5B 1–6 are the magnifications of figures 5A3 and 4 in order to 
highlight the abnormalities. Figure 5B1 shows the normal neuronal tube and 5B2 shows the open neuronal tube in control fetus 
and fetus from mouse with anti-5-HT4 antibodies (NT), axons (Ax) neurons (N). In Figure 5B3 and 5B4 foetal heart tissues, 
from control (5B3) and from mouse with anti-5-HT4 antibodies (5B4) are shown. Dotted arrow shows size and form abnor-
malities. Figure 5B5 and 6 show the higher magnification of the heart from control fetus (5B5) and fetus from mouse with anti-
5-HT4 antibodies (5B6). The heart from the fetus in right panel is symmetric (5B4) compared to the fetus from the control 
mouse (5B3), where its heart is asymmetric with distinct and normal formation of apex. Myocardium (M), Pericardium (doted 
arrow), fibroblast (arrow)BMC Developmental Biology 2007, 7:34 http://www.biomedcentral.com/1471-213X/7/34
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pregnancy was between 5 and 7, which was similar to the
control group. However, the number of fetuses of immu-
nized mice decreased from 12th to 18th GD (7 to 2, respec-
tively). This was in accordance with the titer of circulating
antibodies in the mothers. The latter was also observed in
two littermates, where one mouse gave birth to 2 and the
other to 6 pups. Here we observed again that the titer of
circulating antibodies for the mother with just two pups
was 7 times higher than the mouse with 6 pups.
In this study, we demonstrated that 5-HT4 receptors are
expressed already at the 8th GD (in ectoderm), at least for
the 5-HT4(a) isoform. We also provided evidence for the
functionality of the anti-receptor antibodies, since 1) they
decreased fertility as shown by the increased number of
mating for a successful litter, 2) they decreased the
number of fetuses and pups in relation with the titer of cir-
culating antibodies, 3) they induced morphological and
functional abnormalities both in peripheral and central
organs. In our earlier study [12] we demonstrated that
anti-5-HT4 antibodies passively transferred from mother
to the pups could induce atrioventricular block type I and
II (AVB), tremor and skin lesions. Here we confirmed the
presence of malformation in some cases and could corre-
late its incidence with the expression of the receptor and
titre of the anti-receptor antibodies. This means that at
high concentration of transferred anti-receptor antibodies
the chance of malformation is considerably higher, since
21-days post mating either the number of pups decreased
or no labour was issued. The effect of anti-5-HT4 antibod-
ies could be through their binding to at least 5-HT4(a)
receptor isoform, since it is already expressed from 8th GD.
It has been shown that antibodies against the second
extracellular loop of the receptor block the effect of serot-
onin in human cardiomyocytes [10,28]. In embryonic
heart muscle expression of vascular α-actin has been dem-
onstrated. Alpha-actin acts as a precursor in immature
contractile structures, when the embryonic heart just starts
to beat, and might only gradually be replaced by the
mature cardiac isoform [35-37]. For this reason we used
α-smooth muscle actin as a marker for heart develop-
ment. Our observation that myocardium of mouse fetus
with circulating maternal anti-5-HT4 antibodies has less or
no immunoreactivity for α-actin smooth muscle could be
due to delayed maturation of fetal myocardium in immu-
nized animals. However although the presences of anti-
Ro52 autoantibodies cross reacting with SEL of 5-HT4
receptors shows a good correlation with the prevalence for
neonatal lupus their pathogenic role cannot be general-
ized. We have shown this in our previous work [38]. This
could be due to at one hand that the tested sera were from
pretreated pregnant women with lupus. In no studies yet
published the blood samples are collected following the
same period of pregnancy. Beside the important fluctua-
tion of circulating autoantibodies makes the exploration
even harder. On the other hand we don't have any idea
about the expression of the 5-HT4 receptor during human
embryogenesis. Therefore we cannot draw any general
conclusion. In mice (BALB/c) with no known autoim-
mune genetic background, therefore requiring no treat-
ment, only the presence of 5-HT4  receptor antibodies
induced anomalies in fetus, which coincide with the
receptor expression. Here we could postulate that the SEL
of 5-HT4 receptor could be a pathogenic target for autoan-
tibodies
Although the effect of the antibodies seems to be through
the inhibition of the serotonin signal we however have no
evidence for its cellular mechanism.
Finally, we also show that immunomodulation of 5-HT4
receptor activity, during embryogenesis, is an honorable
alternative to the gene knockout technique. Since the
receptor is already expressed and functional, modulating
or inhibiting its activity will not activate any genetically
compensatory mechanism. Therefore, its activity and
physiological role can be explored independently.
Taken together, our results demonstrate that 5-HT4 recep-
tors are crucial for embryonic development of the cardio-
vascular and central nervous systems in BALB/c mice.
Coincidence of anti-receptor antibodies and expression of
5-HT4 receptor results in anatomical abnormalities. Fur-
ther studies are needed to highlight the function of differ-
ent receptor isoforms during embryogenesis.
Methods
1. Animals
Female adult rabbits (n = 4), female (n = 15) and male (n
= 16) BALB/c mice were purchased from Janvier (Tours,
Table 2: Peptide sequences derived from human 5-HT4 receptors
Protein Peptide Sequence
5-HT4 (165–185) G21V GIIDLIEKRKFNQNSNSTYCV
5-HT4(a) (365–387) Y23F (Y)GHHQELEKLPIHNDPESLESCF
5-HT4(d) (354–360) C7F (C)THVLRF
Peptide residues covering second extracellular loop of serotoninergic 5-HT4 receptor (G21V), and residues covering C-terminal end of 5-HT4(a) 
(Y23F) and 5-HT4(d) (C7F).BMC Developmental Biology 2007, 7:34 http://www.biomedcentral.com/1471-213X/7/34
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France). The animals were kept on a 12:12-h light-dark
cycle (lights on at 6:00 AM) at 21 ± 1°C ambient temper-
ature. Water and food were available ad libitum through-
out the experiments.
2. Peptides
A peptide corresponding to the second extracellular loop
of h5-HT4 receptor (G21V) [10,9], two other peptides cor-
responding to C- terminal ends of the 5-HT4 isoforms h5-
HT4(a) (Y23F) and h5-HT4(d) (C7F) were synthesized as
previously described (Table 2) [10,29]. Their structure
and purity were checked by mass-spectrometry and HPLC.
3. Induction of anti-peptide antibodies
Eight female adult rabbits (2.5–2.7 kg) were immunized
with either Y23F or C7F peptides. Four female rabbits
were immunized with 200 μg of peptide Y23F with 1 mg
of mBSA. Prime injections were given in CFA. The peptide
C7F was conjugated to BSA using SBA prior to administra-
tion to other four rabbits. The peptide was coupled
according to the following procedure. All sulphydryl
groups on BSA (4 mg) were blocked with 0.5 M iodoaceta-
mide in a coupling buffer (pH = 7) composed of K2HPO4
(100 mM), EDTA (1 mM) and sodium azide (0.02%). The
mixture was dialyzed 3 times 1 liter, against the coupling
buffer without sodium azide. Thereafter 30 mg (0.13
mmol) of SBA was added to 4 mg of saturated BSA in the
presence of 0.25 ml of dimethylformamide and diluted
with coupling buffer to the final volume of 3 ml. SBA con-
jugated BSA was separated from the unconjugated ones
on a G-25 Sephadex column (2.2 × 27 cm) and dialyzed
against coupling buffer (3 times 1 liter). Finally 3.4 mg/ml
of activated BSA molecule was mixed with 1.6 mg of C7F
peptide. It was then dialyzed against the coupling buffer
and stored at -20°C. Rabbits were immunized with an
equivalent of 200 μg of BSA conjugated C7F in presence
of CFA. Thereafter rabbits received 3 booster injections
with three weeks interval where CFA was replaced with
Incomplete Freund Adjuvant (IFA). They were bled and
the presence of anti-peptide antibodies was checked.
Female BALB/c mice (n = 5) were immunized with 15 μg/
mouse of peptide G21V together with 100 μg/mouse
mBSA supplemented with PBS/CFA (50% v/v). Two
booster injections were thereafter administered with 3
weeks intervals, where CFA was replaced with IFA. Con-
trol mice (n = 5) received just CFA and IFA. Mice were bled
one week after each booster injection and sera were tested
for the presence of the anti-peptide antibodies.
4. Affinity purification
Y23F was fixed on carboxyl activated ECH Sepharose
beads (Amersham Pharmacia, Sweden), and C7F or G21V
peptides were fixed on thiol activated Sepharose beads
(Amersham Pharmacia, Sweden) according to the stand-
ard procedures. Immunoglobulins from the immunized
rabbit sera as well as lupus patient plasmaphereses with
positive activity on G21V peptide in ELISA, were precipi-
tated with 33% saturated ammonium sulfate and exten-
sively dialyzed over night against PBS. Immunoglobulins
were thereafter diluted 10–15 times with filtered PBS,
before passing through the affinity columns at 4°C for 3
h. After wash out, the anti-peptide polyclonal antibodies
were eluted with 3 M KSCN and dialyzed immediately
against 6 liters PBS at 4°C overnight.
(A) Shows in heart decreased fibroblast immunoreactivity in  fetus from a mouse with anti-5-HT4 antibodies Figure 6
(A) Shows in heart decreased fibroblast immunoreactivity in 
fetus from a mouse with anti-5-HT4 antibodies. Hearts from 
a control fetus is shown in A (100×) and D (1000×) and from 
fetus affected by anti-5-HT4 antibody is shown in B (100×) 
and D (1000×). The presence of immunocomplex between 
anti-αSMA antibodies and heart tissue is revealed with DAB 
(orange colour in A and B) and counterstained with hema-
toxyline (Harris) as it shown in higher magnification in C and 
D. Figure 6B. Represents the estimated immunoreactivity as 
measured by densitometry in heart tissues from control fetus 
and fetus from mouse with anti-5-HT4 antibodies (expressed 
in absorbance unit/pixel area, AU/px2)BMC Developmental Biology 2007, 7:34 http://www.biomedcentral.com/1471-213X/7/34
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5. Enzyme- linked immunosorbent assay (ELISA)
Microtitre plates (Falcon, Canada) were coated with 5 μg/
ml of peptide (50μl/well) in coating buffer (carbonate
buffer 0.1 M, pH = 9.6) for 1 h at 37°C. After saturation
with 1% BSA in PBS supplemented with 0.1% Tween 20
(blocking buffer), the plates were incubated with increas-
ing dilutions (10-2 to 10-6) of sera from immunized and
control rabbits for 1 h at 37°C. After several washes with
PBS-Tween, the plates were allowed to react with affinity-
purified goat anti-rabbit IgG, Fc fragment specific anti-
bodies conjugated to horse-radish peroxidase for 1 h and
revealed with 3,3',5,5'-tetramethyl benzidine in the pres-
ence of H2O2. Reaction was stopped with 1 N HCl and
absorbance was read at 450 nm in a microplate reader.
Inhibition immunoassay was performed as previously
described [9]. Before using affinity purified rabbit polyclo-
nal anti-5-HT4a and d antibodies in ELISA as described
above, the antibodies were diluted 1/12800 in blocking
buffer and incubated with decreasing concentrations (10 -
0.04 μg/ml) of either Y23F or C7F respectively for 1 h at
37°C.
6. Cell culture and transfection
Non-transfected CHO cells were cultivated in Dulbecco's
Modified Eagle's Medium (DMEM) (Sigma Aldrich) sup-
plemented with 10% bovine fetal serum (BFS), 100 U/ml
penicillin, 100 μg/ml streptomycin. The cells were incu-
bated in a humidified incubator at 37°C under an atmos-
phere of 5% CO2. Semi-confluent CHO cells were
transfected as previously described by [30]. Briefly, trans-
fection was performed using a mixture of the vector poly-
ethyleneimine (PEI) and plasmids corresponding to h5-
HT4 receptor isoforms (a) or (d) at a ratio of 20 nM PEI/
mg of DNA. The cells were incubated for 5 h at 37°C with
serum free DMEM supplemented with 100 U/ml penicil-
lin, 100 μg/ml streptomycin. This was followed by incu-
bation in BFS supplemented medium for 24 h.
7. Immunocytochemistry
CHO cells expressing the 5-HT4 receptor isoforms (a) and
(d) as well as non-transfected cells were deposited on
Superfrost Plus slides and fixed for 2 min in paraformal-
dehyde 4%. They were washed with PBS-Tween 20 (0.1%)
and saturated with PBS supplemented with 0.1% Tween
20 and 0.1% BSA for 1 h at room temperature. They were
incubated with 1/200 affinity purified anti-peptide anti-
bodies corresponding to each isoform for 2 h at room
temperature followed by 1 μg/ml 4',6-diamidino-2-phe-
nylindole (DAPI) (Sigma Aldrich) and Alexa Fluor 594
goat anti-rabbit IgG (H+L) (Molecular Probes, Oregon,
USA) diluted 1/500 for 1 h at the same temperature. The
slides were mounted using DAKO Fluorescent mounting
medium (DAKO CORPORATION, Carpinteria).
8. Flow cytometry analyses
Stably transfected 5-HT4(g) and M2 muscarinic CHO cells
were cultured and growth to confluence separately in
DMEM medium supplemented with 10% heat inactivated
BFS. Twenty-four hours before experiment, cells were har-
vested with chilled Trypsin/EDTA washed and dispatched
at a concentration of 105 cells/tube in pretreated FACS
tubes, in order to prevent cell attachment on the tube wall.
Affinity purified rabbit polyclonal anti-G21V (1/500),
mouse sera (1/100) and affinity purified anti-G21V (1/
50) from a lupus patient were incubated with the cells for
1 h in normal culture condition. Cells were washed 3
times with DMEM. They were then incubated with either
FITC-conjugated goat anti-rabbit or FITC-conjugated goat
anti-mouse or biotinylated goat anti-human antibodies in
DMEM supplemented with 1% goat sera for 1 h in normal
culture conditions. After 3 washes only tubes treated with
anti-human antibodies were further incubated with FITC-
conjugated streptavidin for 30 min in normal culture con-
ditions.
Cells were analyzed by flow cytometry with a FACSCali-
bur® . At least 10,000 events were acquired for each exper-
iment using the CellQuest 3.3 software (Becton
Dickinson, Pont de Claix, France). The data were proc-
essed with the same program using analyses option.
9. Reverse Transcription – Polymerase Chain Reaction 
(RT-PCR) and southern blot
Balb/c mice (n = 8) were mated and the fetuses were col-
lected at 8th, 12th, 16th 18th, 20th GD and 1 DPN. From the
same litter, half of fetus was used for RT-PCR and the
other half was frozen down for immunohistochemistry
(see below). Total RNA was prepared from mouse tissues
using the Trizol RNA purification system (Life Technolo-
gies Inc.). After purification, RNA was treated with DNase
I (Life Technologies Inc.) and 5 μg of total RNA was then
hybridized with oligo(dT) primer and reverse transcribed
using Superscript reverse transcriptase II (Life Technolo-
gies Inc.). The resulting single strand cDNAs were used as
templates in PCR reactions using a specific primer pair for
the m5-HT4R (5'-CCTGTGCTGTATTTCCCTGG-3'; 5'-
GAATGGGGGGTCTTTTGTAG-3'). This primer couple
selective of the common part of mouse 5-HT4 receptor iso-
form allows the amplification of a single DNA band
migrating at 688 bp (base pair). The sequence of β-actin
primers has been previously described [5]. PCR reactions
were performed using the following cycle conditions:
denaturation for 1 min at 94°C, annealing for 30 s at
55°C, and extension for 1 min 30 sec at 72°C with a final
extension step for 8 min at 72°C. The PCR products were
electrophoresed on 1.5% agarose gel containing 0.01%
ethidium bromide and photographed under U.V. irradia-
tion. For Southern blot, PCR products were transferred to
Zetaprobe membrane (Biorad). The following primer 5'-BMC Developmental Biology 2007, 7:34 http://www.biomedcentral.com/1471-213X/7/34
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AGGATGATGAGGAAGGCACG-3' was labeled with 32P
using the random primer DNA labeling kit (Life Technol-
ogies Inc.), and used as an internal probe for hybridiza-
tion. Hybridization was performed at 57°C for 12 h in a
Church buffer (0.5 M NaHPO4 pH 7.2, 1 mM EDTA, 7%
SDS) containing 100 μg/ml of denatured salmon sperm
DNA. The membrane was revealed using a phosphoim-
ager (Storm, Molecular Dynamics).
10. Immunofluorescence and histochemistry
Frozen fetuses 12th 18th GD, pups and adult brains were
subjected to serial cuts at 5-μm thickness, using a Leica
cryostat. After fixing the tissues with 1% paraformalde-
hyde for 5 min at room temperature, they were permeabi-
lized in PBS at pH 7.4, supplemented with 0.1% Triton-X
for 3 min. The tissue was saturated with blocking buffer
(PBS, 1% BSA, 0.1%Tween) for 1 h at room temperature.
Affinity purified anti-peptide antibodies corresponding to
each isoform were incubated for 2 h (1/200). After three
washes in PBS, the tissues were incubated for 1 h at room
temperature with Alexa Fluor 594 goat anti-rabbit IgG
(H+L) (1/500) and visualized under a Leica epifluores-
cence microscope and photographed.
Fetuses at 12th GD were collected and fixed overnight in
4% formaldehyde/PBS solution. They were then dehy-
drated according to the standard procedures. Paraffin
embedded fetuses were cut on the sagital axis at 4 μm
mounted on superfrost plus slides. They were then dried
over night at 57°C. Sections were rehydrated and satu-
rated for 1 h in TBS-Tween 0.1% supplemented with 1%
goat sera. Slides were thereafter incubated with anti-
Actin,  α smooth muscle (α-ASM) mouse monoclonal
(Sigma-Aldrich St Louis). After three washes Vectastain
ABC KIT goat anti-mouse immunoglobulins (Vector labo-
ratories, Burlingame, CA) was used according to the man-
ufacturer recommendations. Finally after extensive
washes (5 times in TBS Tween) the bound antibodies were
revealed using DAB chromogen KIT (DakoCystomation,
Carpinteria, CA). The slides were counter stained with
hematoxylin for 20 sec and washed for 15 min under
demineralized water. They were then dehydrated and
mounted according to the standard procedures. The
immunoreactivity in fetal heart was quantified in gray
scale using MacBas densitometry program on 5 serial
slices and 10 different regions for each slide.
11. Histology
Fetuses at 12th GD were collected and fixed over night in
4% formaldehyde/PBS solution. They were then dehy-
drated according to the standard procedures. Paraffin
embedded fetuses were cut on the sagital axis at 4 μm and
subjected to standard hematoxilin/eosin coloration.
List of Abbreviations
Atrio-ventricular block (AVB), Chinese Hamster Ovary
(CHO), Complete Freund's Adjuvant (CFA), congenital
heart block (CHB), 4',6-diamidino-2-phenylindole
(DAPI), Dulbecco's Modified Eagle's Medium (DMEM),
day post natal (DPN) Enzyme- Linked immunosorbent
assay (ELISA), ethylenendiaminetetraacetic acid (EDTA),
gestation days (GD), human 5-HT4 receptor (h5-HT4),
Incomplete Freund Adjuvant (IFA), mouse 5-HT4 receptor
(m5-HT4), methylated bovine serum albumin (mBSA),
neonatal lupus erythematosus (NLE), one day postnatal
(DPN), polyethyleneimine (PEI), Reverse Transcription –
Polymerase Chain Reaction (RT-PCR), N-succinimidyl
bromoacetate (SBA), second extracellular loop (SEL).
Authors' contributions
All authors read and approved the final manuscript.
RK has performed ELISA, Western blot and immunohisto-
logical experiments.
SG has also performed ELISA, contributed to the in vivo
studies, and explored the fetal abnormalities.
FL has performed mRNA studies.
RF has revised critically and contributed with important
intellectual input regarding this manuscript.
SM has revised critically and contributed with important
intellectual input regarding this manuscript.
JH has made substantial contributions to conception and
design of the manuscript
PE has induced antibodies, performed histological stud-
ies, conducted the experimental part and made substan-
tial contributions to conception and design of the
manuscript.
Acknowledgements
RK has a fellowship of the Egyptian government. Part of this work was 
financed by the Centre National de la Recherche Scientifique, France. The 
authors would like to thank Dr M. Decossas for her help in histology and 
improvement of image quality.
References
1. Langlois M, Fischmeister R: 5-HT4 receptor ligands: applications
and new prospects.  J Med Chem 2003, 46:319-44.
2. Bockaert J, Claeysen S, Compan V, Dumuis A: 5-HT4 receptors.
Curr Drug Targets CNS Neurol Disord 2004, 3:39-51.
3. Brattelid T, Kvingedal AM, Krobert KA, Andressen KW, Bach T, Hys-
tad ME, Kaumann AJ, Levy FO: Cloning, pharmacological charac-
terisation and tissue distribution of a novel 5-HT4 receptor
splice variant, 5-HT4(i).  Naunyn Schmiedebergs Arch Pharmacol
2004, 369:616-28.
4. Bender E, Pindon A, van Oers I, Zhang YB, Gommeren W, Verhasselt
P, Jurzak M, Leysen J, Luyten W: Structure of the human serot-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Developmental Biology 2007, 7:34 http://www.biomedcentral.com/1471-213X/7/34
Page 11 of 11
(page number not for citation purposes)
onin 5-HT4 receptor gene and cloning of a novel 5-HT4
splice variant.  J Neurochem 2000, 74:478-89.
5. Blondel O, Gastineau M, Dahmoune Y, Langlois M, Fischmeister R:
Cloning, expression, and pharmacology of four human 5-
hydroxytryptamine 4 receptor isoforms produced by alter-
native splicing in the carboxyl terminus.  J Neurochem 1998,
70:2252-61.
6. Medhurst AD, Lezoualc'h F, Fischmeister R, Middlemiss DN, Sanger
GJ: Quantitative mRNA analysis of five C-terminal splice var-
iants of the human 5-HT4 receptor in the central nervous
system by TaqMan real time RT-PCR.  Brain Res Mol Brain Res
2001, 90:125-34.
7. Varnas K, Halldin C, Pike VW, Hall H: Distribution of 5-HT4
receptors in the postmortem human brain – an autoradio-
graphic study using [125I] SB 207710.  Eur Neuropsychopharma-
col 2003, 13:228-34.
8. Claeysen S, Sebben M, Becamel C, Bockaert J, Dumuis A: Novel
brain-specific 5-HT4 receptor splice variants show marked
constitutive activity: role of the C-terminal intracellular
domain.  Mol Pharmacol 1999, 55:910-20.
9. Claeysen S, Sebben M, Journot L, Bockaert J, Dumuis A: Cloning,
expression and pharmacology of the mouse 5-HT(4L) recep-
tor.  FEBS Lett 1996, 398:19-25.
10. Eftekhari P, Salle L, Lezoualc'h F, Mialet J, Gastineau M, Briand JP, Isen-
berg DA, Fournie GJ, Argibay J, Fischmeister R, Muller S, Hoebeke J:
Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4
serotoninergic receptor could explain neonatal lupus con-
genital heart block.  Eur J Immunol 2000, 30:2782-90.
11. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, Lee LA,
Provost TT, Reichlin M, Rider L, Rupel A, Saleeb S, Weston WL, Sko-
vron ML: Autoimmune-associated congenital heart block:
demographics, mortality, morbidity and recurrence rates
obtained from a national neonatal lupus registry.  J Am Coll Car-
diol 1998, 31:1658-66.
12. Eftekhari P, Roegel JC, Lezoualc'h F, Fischmeister R, Imbs JL, Hoebeke
J: Induction of neonatal lupus in pups of mice immunized
with synthetic peptides derived from amino acid sequences
of the serotoninergic 5-HT4 receptor.  Eur J Immunol 2001,
31:573-9.
13. Berthouze M, Ayoub M, Russo O, Rivail L, Sicsic S, Fischmeister R,
Berque-Bestel I, Jockers R, Lezoualc'h F: Constitutive dimeriza-
tion of human serotonin 5-HT4 receptors in living cells.  FEBS
Lett 2005, 579:2973-2980.
14. Pike VW, Halldin C, Nobuhara K, Hiltunen J, Mulligan RS, Swahn CG,
Karlsson P, Olsson H, Hume SP, Hirani E, Whalley J, Pilowsky LS,
Larsson S, Schnell PO, Ell PJ, Farde L: Radioiodinated SB 207710
as a radioligand in vivo: imaging of brain 5-HT4 receptors
with SPET.  Eur J Nucl Med Mol Imaging 2003, 30:1520-8.
15. Lambert HW, Lauder JM: Serotonin receptor agonists that
increase cyclic AMP positively regulate IGF-I in mouse man-
dibular mesenchymal cells.  Dev Neurosci 1999, 21:105-12.
16. Lambert HW, Weiss ER, Lauder JM: Activation of 5-HT receptors
that stimulate the adenylyl cyclase pathway positively regu-
lates IGF-I in cultured craniofacial mesenchymal cells.  Dev
Neurosci 2001, 23:70-7.
17. Shuey DL, Sadler TW, Lauder JM: Serotonin as a regulator of
craniofacial morphogenesis: site specific malformations fol-
lowing exposure to serotonin uptake inhibitors.  Teratology
1992, 46:367-78.
18. Shuey DL, Sadler TW, Tamir H, Lauder JM: Serotonin and mor-
phogenesis. Transient expression of serotonin uptake and
binding protein during craniofacial morphogenesis in the
mouse.  Anat Embryol (Berl) 1993, 187:75-85.
19. Yavarone MS, Shuey DL, Sadler TW, Lauder JM: Serotonin uptake
in the ectoplacental cone and placenta of the mouse.  Placenta
1993, 14:149-61.
20. Yavarone MS, Shuey DL, Tamir H, Sadler TW, Lauder JM: Serotonin
and cardiac morphogenesis in the mouse embryo.  Teratology
1993, 47:573-84.
21. Moiseiwitch JR, Lauder JM: Serotonin regulates mouse cranial
neural crest migration.  Proc Natl Acad Sci USA 1995, 92:7182-6.
22. Moiseiwitch JR, Lauder JM: Regulation of gene expression in cul-
tured embryonic mouse mandibular mesenchyme by serot-
onin antagonists.  Anat Embryol (Berl) 1997, 195:71-8.
23. Moiseiwitch JR, Tamir H, Raymond JR, Lauder JM: Regulation by
serotonin of tooth-germ morphogenesis and gene expres-
sion in mouse mandibular explant cultures.  Arch Oral Biol 1998,
43:789-800.
24. Nebigil CG, Maroteaux L: A novel role for serotonin in heart.
Trends Cardiovasc Med 2001, 11:329-35.
25. Choi DS, Ward SJ, Messaddeq N, Launay JM, Maroteaux L: 5-HT2B
receptor-mediated  serotonin morphogenetic functions in
mouse cranial neural crest and myocardiac cells.  Development
1997, 124:1745-5.
26. Launay JM: Serotonin and the cardiovascular system: role of
the serotoninergic 5-HT 2B receptor.  Bull Acad Natl Med 2003,
187:117-25.
27. Song GL, Tang M, Liu CJ, Luo HY, Liang HM, Hu XW, XI JY, Fleis-
chmann B, Hescheler J: Developmental changes in functional
expression and β-adrenergic regulation of If in the heart of
mouse embryo.  Cell Reas 2002, 12:385-94.
28. Salle L, Eftekhari P, Aupart M, Cosnay P, Hoebeke J, Argibay JA:
Inhibitory activity of antibodies against the human atrial 5-
HT (4) receptor.  J Mol Cell Cardiol 2001, 33:405-17.
29. Neimark J, Briand JP: Development of a fully automated mul-
tichannel peptide synthesizer with integrated TFA cleavage
capability.  Pept Res 1993, 6:219-28.
30. Mialet J, Berque-Bestel I, Eftekhari P, Gastineau M, Giner M, Dah-
moune Y, Donzeau-Gouge P, Hoebeke J, Langlois M, Sicsic S, Fisch-
meister R, Lezoualc'h F: Isolation of the serotoninergic 5-
HT4(e) receptor from human heart and comparative analy-
sis of its pharmacological profile in C6-glial and CHO cell
lines.  Br J Pharmacol 2000, 129:771-81.
31. Compan V, Zhou M, Grailhe R, Gazzra RA, Martin R, Gingrich J, Dum-
muis A, Brunner D, Bockaert J, Hen R: attenuated response to
stress and novelty and hypersensitivity to seizures in 5-HT4
receptor knockout mice.  J Neuroscience 2004, 24:412-419.
32. Reid CA, Coleman HA, Finkenstein DI, Horne MK, Drago J: Null
mutation of the α4 nicotinic receptor subunit increases the
propensity of muscarinic-mediated neuronal bursting in
mouse hippocampl slices.  J Neuropharm 2006, 51:587-596.
33. Walz R, Castro RM, Veloasco TR, Carlotti CG Jr, Sakamoto AC,
Brentani RR, Martins VR: Cellular prion:implications in seizures
and epilepsy.  Cell Mol Neurobiol 2002, 3:249-57.
34. Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK,
Holtsberg FW, Mattson MP: Altered neuronal and microglial
responses to excitotoxic and ischemic brain injury in mice
lackingTNF receptors.  Nat Med 1996, 7:788-94.
35. Gringrich JA, Hen R: The broken mouse: the role of develop-
ment, plasticity and environment in the interpretation of
phenotypic changes in knockout mice.  Curr Opin Neurobiol 2000,
10:146-152.
36. Eppenberger-Eberhardt M, Flamme I, Kurer V, Eppenberger HM:
Reexpression of α-smooth muscle actib isoform in culture
adult rat cardiomyocytes.  Dev Biol 1990, 139:269-278.
37. Komuro I, Yazaki Y: Control of cardiac gene expression by
mechanical stress.  Annu rev Physiol 1993, 55:55-75.
38. Kamel R, Eftekhari P, Clancy R, Bouyon J, Hoebeke J: Autoantibod-
ies against the serotoninergic 5-HT4 receptor and congeni-
tal heart block: a reassessment.  J Autoimmun 2005, 25:72-6.